Alpha Aesthetics Partners Expands Presence in California and Enters Colorado through Partnership with Preva Aesthetics

Alpha Aesthetics Partners, a leader in the medical aesthetics specialty and a portfolio company of Thurston Group, is proud to announce its partnership with Preva Aesthetics, a premier aesthetics practice led by Michelle Paty, MSN, CPNP-AC, FNP-C. Founded with a focus on preventative aesthetics and natural-looking outcomes, Preva Aesthetics has built a loyal following through […]

Alpha Aesthetics Partners Expands Presence in California and Enters Colorado through Partnership with Preva Aesthetics Read More »

DOMA Acquires MPA Services

Agenda Health is honored to have served as the exclusive sell-side advisor to MPA Services in their recent acquisition by DOMA. This transaction marks a significant step forward in expanding Doma’s intellectual and developmental disabilities (IDD) footprint across Ohio. Through this partnership, Doma will now serve residents throughout the greater Dayton area, furthering their commitment

DOMA Acquires MPA Services Read More »

Medtronic Announces Intent to Acquire SPR Therapeutics, Inc., Expanding Care Options for People Living with Chronic Pain

Medtronic plc (NYSE: MDT), a global healthcare technology leader, announces its intent to acquire SPR Therapeutics, Inc. (SPR), a privately held medical technology company and a recognized leader in temporary, percutaneous peripheral nerve stimulation (PNS) therapies for chronic pain management. The transaction consists of an upfront cash payment of approximately $650 million for all the

Medtronic Announces Intent to Acquire SPR Therapeutics, Inc., Expanding Care Options for People Living with Chronic Pain Read More »

Wellgistics Health and Datavault AI to Form DelivMeds AI via PharmacyChain™ License Expansion and Acquisitions of QOLPOM Biometric Health Data and Drone Logistics IP and Majority of Tollo Health

Datavault AI Inc. (“Datavault AI” or the “Company”) (NASDAQ:DVLT), a provider of data monetization, credentialing, digital engagement, and real-world asset (‘RWA’) tokenization technologies, has entered into a fully binding term sheet (the “Binding Term Sheet”) with Wellgistics Health, Inc. (“Wellgistics”) (NASDAQ:WGRX), a health information technology leader, integrating proprietary pharmacy dispensing optimization artificial intelligence (AI) platform

Wellgistics Health and Datavault AI to Form DelivMeds AI via PharmacyChain™ License Expansion and Acquisitions of QOLPOM Biometric Health Data and Drone Logistics IP and Majority of Tollo Health Read More »

Engage Bio Acquired by Lilly to Accelerate Development of Non-Viral Genetic Medicines

Engage Biologics Inc. (“Engage”), a preclinical biotechnology company pioneering non-viral DNA delivery, announces that it has been acquired by Eli Lilly and Company (“Lilly”). Engage is developing the Tethosome platform, a novel non-viral DNA delivery system designed to overcome key limitations in DNA delivery, including potency, tolerability, and redosability. The platform combines engineered DNA payloads

Engage Bio Acquired by Lilly to Accelerate Development of Non-Viral Genetic Medicines Read More »

Garonit Pharmaceutical Announces Acquisition of Former Siemens Healthineers Facility in Flanders, NJ to Expand U.S. Manufacturing

Garonit Pharmaceutical, Inc., a U.S.-based manufacturer of active pharmaceutical ingredients (APIs) and finished dosage products, is pleased to announce the acquisition of the former Siemens Healthineers manufacturing facility in Flanders, New Jersey. The 320,000+ square foot facility, situated on approximately 32 acres, will serve as a major hub for Garonit’s expanding U.S. operations, supporting future

Garonit Pharmaceutical Announces Acquisition of Former Siemens Healthineers Facility in Flanders, NJ to Expand U.S. Manufacturing Read More »

Woodside Health Acquires Medical Offices at Maitland

Woodside Health is pleased to announce the acquisition of Medical Offices at Maitland, a multi-building healthcare campus located in the Orlando MSA. The property consists of six single-story medical office buildings totaling approximately 81,500 rentable square feet situated on 11.3 acres along Forest City Road, a major thoroughfare serving the northern Orlando area. Built between

Woodside Health Acquires Medical Offices at Maitland Read More »

Highlights of the 22nd McGuireWoods Healthcare Private Equity and Finance Conference

McGuireWoods convened its 22nd Annual Healthcare Private Equity and Finance Conference in Chicago on April 29-30, 2026, gathering investors, operators, lenders, advisers and executives from across the country. The two days came as healthcare private equity faces heightened regulatory scrutiny, reimbursement uncertainty and AI-driven disruption amid an improving M&A market. One theme cut across the

Highlights of the 22nd McGuireWoods Healthcare Private Equity and Finance Conference Read More »

CMS Hospice and Home Health Agency Moratorium: Impact on M&A and Ownership Changes

CMS’s new nationwide moratorium on hospice and home health agency enrollments is an immediate M&A disruptor. For the next six months, and potentially longer, any deal structure requiring a new Medicare enrollment number (or triggering a new Medicare provider agreement) is effectively off the table. Only change of information (COI)-eligible equity deals, carefully calibrated against

CMS Hospice and Home Health Agency Moratorium: Impact on M&A and Ownership Changes Read More »

Addus CEO: Moratorium Has Little to No Impact on Growth, Valuations

Addus HomeCare Corporation (Nasdaq: ADUS) is actively pursuing acquisitions of size – and does not anticipate any impact to its growth strategy from the recently-announced moratorium on home health Medicare enrollment. As the Centers for Medicare & Medicaid Services’ (CMS) new moratoria affect only home health and hospice, Addus’ personal care services segment is not

Addus CEO: Moratorium Has Little to No Impact on Growth, Valuations Read More »

Scroll to Top